Results 251 to 260 of about 38,510 (295)

Efficacy and Safety of L‐Carnosine‐Containing Hyaluronate Injection for Facial Skin Hydration and Brightness: A Randomized, Controlled, Evaluator‐Blinded Trial

Journal of Cosmetic Dermatology, Volume 25, Issue 7, July 2026.
ABSTRACT Background L‐carnosine, a dipeptide with superior antioxidant and antiglycation properties, serves as the core active component in this study. We aimed to evaluate the efficacy and safety of a novel injectable composite solution, which features L‐carnosine in combination with non‐crosslinked sodium hyaluronate, glycine, alanine, proline, and ...
Zhanhong Li, Jingfang Sun, Zhehu Jin, Wei Guo, Aili Cui, Huaigu Wang, Jiahua Wang, Xiaoyi Qiu, Heyang Xi, Yao Zhang, Lu Zhang, Ligen Xuan, Lingzhi Shi, Yangliang Yi, Huiyin Qiu, Fangke Guan, Yaling Xie, Zhouwei Liu, Lili Liang, Haijun Yang, Chunfang Chen, Huiying Wang, Xiaoling Sun, Fengsheng Che, Qiong Meng   +24 more
wiley   +1 more source

Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs. [PDF]

J Anim Physiol Anim Nutr (Berl)
Bridglalsingh S, Archer-Hartmann S, Azadi P, Barbier de La Serre C, Remillard RL, Sunvold GD, Bartges JW.   +6 more
europepmc   +1 more source

Cardiac remodelling in type 2 diabetes: Pathophysiological mechanisms and opportunities for multiscale computational modelling and simulation

The Journal of Physiology, Volume 604, Issue 13, Page 5170-5199, 1 July 2026.
Abstract figure legend Overview of multiscale cardiac remodelling in type 2 diabetes and how to model and simulate these changes using a human‐based, multiscale computational framework. Cardiac remodelling in type 2 diabetes occurs at ionic channel, protein, cellular, tissue and whole‐organ level, affecting the electrophysiological function, mechanical
Ambre Bertrand, Jakub Tomek, Blanca Rodriguez   +2 more
wiley   +1 more source

Racemisation of Amino Acids: From Synthetic Challenge to Biological Significance

ChemBioChem, Volume 27, Issue 11, 15 June 2026.
Racemisation, once considered an undesirable synthetic side reaction, also occurs naturally in amino acids and influences biological processes. Evidence links stereochemical conversion to ageing, protein turnover, and cellular development. This review examines mechanisms, control strategies in synthesis, applications and implications in physiology ...
Othman Al Musaimi
wiley   +1 more source

Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics

Analytical Biochemistry, 2004
Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. AGEs bind cell-surface receptors including the receptor for advanced glycation end products (RAGE). The dependence of RAGE binding on specific biochemical characteristics of AGEs is currently unknown.
Jeroen Degroot, Johan M Tekoppele, Thomas E Hughes   +2 more
exaly   +5 more sources

Modulation of Soluble Receptor for Advanced Glycation End Products Isoforms and Advanced Glycation End Products in Long-Living Individuals

Biomarkers in Medicine, 2021
Background: Circulating levels of soluble receptor for advanced glycation end products (sRAGE) and advanced glycation end products (AGEs) correlate with aging/cardiovascular risk, which is delayed in long-living individuals (LLIs). AGEs/sRAGE isoforms (cleaved RAGE [cRAGE] and secretory RAGE [esRAGE]) ratio is a valuable marker for disease risk ...
Francesco Scavello, Calogero C Tedesco, Stefania Castiglione, Anna Maciag, Elena Sangalli, Fabrizio Veglia, Gaia Spinetti, Annibale A Puca, Angela Raucci   +8 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Cellular signalling of the receptor for advanced glycation end products (RAGE)

Cellular Signalling, 2013
The receptor for advanced glycation end-product (RAGE) is the signal transduction receptor which senses a variety of signalling molecules including advanced glycation end products (AGEs), HMGB1, S100/calgranulins, β-amyloid, phosphatidylserine, C3a and advanced oxidation protein products (AOPPs).
Jianling Xie, JOSÉ D Méndez, Maria Montserrat Aguilar-Hernández   +2 more
exaly   +3 more sources

Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes

Medicinal Research Reviews, 2020
Type 1 diabetes (T1D) is one of the most common chronic diseases manifesting in early life, with the prevalence increasing worldwide at a rate of approximately 3% per annum.
Selena Le Bagge, Amelia K Fotheringham, Sherman S Leung   +2 more
exaly   +2 more sources

Understanding RAGE, the receptor for advanced glycation end products

Journal of Molecular Medicine, 2005
Advanced glycation end products (AGEs), S100/calgranulins, HMGB1-proteins, amyloid-beta peptides, and the family of beta-sheet fibrils have been shown to contribute to a number of chronic diseases such as diabetes, amyloidoses, inflammatory conditions, and tumors by promoting cellular dysfunction via binding to cellular surface receptors.
Angelika, Bierhaus, Per M, Humpert, Michael, Morcos, Thoralf, Wendt, Triantafyllos, Chavakis, Bernd, Arnold, David M, Stern, Peter P, Nawroth   +7 more
openaire   +2 more sources

Receptor for advanced glycation end-products in neurodegenerative diseases

Reviews in the Neurosciences, 2015
AbstractThis review, for the first time, aims to summarize the current knowledge in the emerging field of RAGE (receptor for advanced glycation end-products) studies in neurodegeneration and neurodegenerative diseases. RAGE, a member of the multiligand cell surface immunoglobulin family, has been implicated in numerous pathological conditions – from ...
Judyta, Juranek, Rashmi, Ray, Marta, Banach, Vivek, Rai   +3 more
openaire   +2 more sources